Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Cancer Science|May 6, 2024
CD271 mRNA/hnRNPA2B1 complex promotes proliferation and stemness in oral and head and neck squamous cell carcinomaMai Mochizuki, Rie Shibuya-Takahashi, Shin-Ichiro Kanno, et al.
Nature Communications|April 11, 2020
TGFβ suppresses CD8<sup>+</sup> T cell expression of CXCR3 and tumor traffickingAndrew J Gunderson, Tomoko Yamazaki, Kayla McCarty, et al.
Scientific Reports|October 23, 2022
RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancerAkira Nakazato, Mai Mochizuki, Rie Shibuya-Takahashi, et al.
Medical Oncology (Northwood, London, England)|September 22, 2021
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trialYoshinori Imamura, Kaoru Tanaka, Naomi Kiyota, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 26, 2019
CD271 is a negative prognostic factor and essential for cell proliferation in lung squamous cell carcinomaMai Mochizuki, Mao Nakamura, Rie Sibuya, et al.
Japanese Journal of Clinical Oncology|June 25, 2025
Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancerSatoshi Kano, Naomi Kiyota, Ichiro Kinoshita, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2013
Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progressionYasuhiro Yoshimatsu, Yulia G Lee, Yuichi Akatsu, et al.
Cancer Science|March 28, 2022
Establishment of a monoclonal antibody against glycosylated CD271 specific for cancer cells in immunohistochemistryKeitaro Fujii, Shinkichi Morita, Mai Mochizuki, et al.
Journal of Cancer|September 1, 2022
Association between the Co-administration of Histamine H<sub>2</sub> Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score AnalysisTomoko Yamazaki, Ryuji Uozumi, Hitoshi Kawazoe, et al.
The Oncologist|March 31, 2025
Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective studyTakane Watanabe, Hiroki Oka, Kengo Nagashima, et al.
Pageof 11